JP2023514520A5 - - Google Patents
Info
- Publication number
- JP2023514520A5 JP2023514520A5 JP2022546665A JP2022546665A JP2023514520A5 JP 2023514520 A5 JP2023514520 A5 JP 2023514520A5 JP 2022546665 A JP2022546665 A JP 2022546665A JP 2022546665 A JP2022546665 A JP 2022546665A JP 2023514520 A5 JP2023514520 A5 JP 2023514520A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- groups
- cancers
- antibody
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2020-0011222 | 2020-01-30 | ||
| KR20200011222 | 2020-01-30 | ||
| PCT/KR2021/001082 WO2021153984A1 (ko) | 2020-01-30 | 2021-01-27 | 벤조셀레노펜계 화합물, 이를 포함하는 약학적 조성물 및 항체-약물 결합체 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023514520A JP2023514520A (ja) | 2023-04-06 |
| JP2023514520A5 true JP2023514520A5 (enExample) | 2023-09-19 |
| JP7504209B2 JP7504209B2 (ja) | 2024-06-21 |
Family
ID=77079632
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020155441A Active JP7726628B2 (ja) | 2020-01-30 | 2020-09-16 | ベンゾセレノフェン系化合物、これを含む薬学的組成物及び抗体－薬物複合体 |
| JP2022546665A Active JP7504209B2 (ja) | 2020-01-30 | 2021-01-27 | ベンゾセレノフェン系化合物、これを含む薬学的組成物及び抗体－薬物複合体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020155441A Active JP7726628B2 (ja) | 2020-01-30 | 2020-09-16 | ベンゾセレノフェン系化合物、これを含む薬学的組成物及び抗体－薬物複合体 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11576896B2 (enExample) |
| EP (1) | EP4083041A4 (enExample) |
| JP (2) | JP7726628B2 (enExample) |
| KR (2) | KR102894542B1 (enExample) |
| CN (1) | CN115038699B (enExample) |
| AU (1) | AU2021212559B2 (enExample) |
| CA (1) | CA3165524C (enExample) |
| WO (1) | WO2021153984A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7726628B2 (ja) * | 2020-01-30 | 2025-08-20 | エイムドバイオ株式会社 | ベンゾセレノフェン系化合物、これを含む薬学的組成物及び抗体－薬物複合体 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4975278A (en) | 1988-02-26 | 1990-12-04 | Bristol-Myers Company | Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells |
| EP0888301B1 (en) | 1996-03-08 | 2005-08-10 | The Scripps Research Institute | Mcbi analogs of cc-1065 and the duocarmycins |
| EP2354163A3 (en) * | 2005-09-26 | 2013-04-24 | Medarex, Inc. | Conjugates of duocarmycin and anti-CD70 or anti-PSMA antibodies |
| US8940784B2 (en) * | 2006-02-02 | 2015-01-27 | Syntarga B.V. | Water-soluble CC-1065 analogs and their conjugates |
| JP5315060B2 (ja) * | 2006-02-03 | 2013-10-16 | バイオノミックス リミテッド | 置換ベンゾフラン、ベンゾチオフェン、ベンゾセレノフェンおよびインドールおよびそれらのチューブリン重合阻害剤としての使用 |
| TWI412367B (zh) * | 2006-12-28 | 2013-10-21 | 梅達雷克斯有限責任公司 | 化學鏈接劑與可裂解基質以及其之綴合物 |
| KR101418776B1 (ko) * | 2011-09-28 | 2014-07-14 | 사회복지법인 삼성생명공익재단 | 셀레노펜-접합 방향족 화합물, 및 이의 제조 방법 |
| CN103906742A (zh) * | 2011-09-28 | 2014-07-02 | 世宗大学校产学协力团 | 硒吩稠合芳族化合物和其制备方法 |
| KR101460207B1 (ko) * | 2011-12-07 | 2014-11-11 | 세종대학교산학협력단 | 셀레노펜-접합 방향족 화합물을 포함하는 항암제 |
| US9819889B2 (en) * | 2015-08-07 | 2017-11-14 | Omnivision Technologies, Inc. | Method and system to implement a stacked chip high dynamic range image sensor |
| KR101775440B1 (ko) * | 2015-10-07 | 2017-09-06 | 세종대학교산학협력단 | 벤조셀레노펜계 화합물 및 이를 포함하는 항체-약물 결합체 |
| JP7726628B2 (ja) * | 2020-01-30 | 2025-08-20 | エイムドバイオ株式会社 | ベンゾセレノフェン系化合物、これを含む薬学的組成物及び抗体－薬物複合体 |
-
2020
- 2020-09-16 JP JP2020155441A patent/JP7726628B2/ja active Active
- 2020-09-16 KR KR1020200118786A patent/KR102894542B1/ko active Active
-
2021
- 2021-01-27 EP EP21748317.1A patent/EP4083041A4/en active Pending
- 2021-01-27 WO PCT/KR2021/001082 patent/WO2021153984A1/ko not_active Ceased
- 2021-01-27 CN CN202180012034.0A patent/CN115038699B/zh active Active
- 2021-01-27 CA CA3165524A patent/CA3165524C/en active Active
- 2021-01-27 KR KR1020210011551A patent/KR102596247B1/ko active Active
- 2021-01-27 AU AU2021212559A patent/AU2021212559B2/en active Active
- 2021-01-27 JP JP2022546665A patent/JP7504209B2/ja active Active
- 2021-01-29 US US17/161,771 patent/US11576896B2/en active Active
-
2022
- 2022-07-29 US US17/815,958 patent/US11938115B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2545977T3 (es) | Combinaciones de un conjugado de anticuerpo-fármaco anti-HER2 y agentes quimioterapéuticos, y métodos de uso | |
| JP2023514520A5 (enExample) | ||
| TWI880049B (zh) | Kras g12c抑制劑 | |
| US8394795B2 (en) | Pyrazole [3, 4-B] pyridine Raf inhibitors | |
| US8324190B2 (en) | Treatment of proliferative disorders with amino-substituted (E)-2,6- dialkoxystyryl 4-substituted benzylsulfones | |
| EP2265609B1 (en) | Imdizo [4. 5-b] pyridine derivatives used as raf inhibitors | |
| EP2906252B1 (en) | Pyrrolobenzodiazepine-anti-her2 antibody conjugates | |
| JP2013091670A5 (enExample) | ||
| US20120157452A1 (en) | 1h-pyrazolo[3,4-b] pyridine compounds for inhibiting raf kinase | |
| CN102482283A (zh) | Raf抑制剂化合物及其使用方法 | |
| AU774794B2 (en) | 1,2,3,4,5,6-hexahydroazepino(4,5-b)indoles containing arylsulfones at the 9-position | |
| EP2855482A1 (en) | Pyrrolobenzodiazepines | |
| JP2025509217A (ja) | ４－メチル－２－プロパン－２－イル－ピリジン－３－カルボニトリルを調製するための方法 | |
| US11976122B2 (en) | Anti-IL13Rα2 antibodies | |
| US11576896B2 (en) | Benzoselenophene-based compounds, pharmaceutical compositions and antibody-drug conjugates including the same | |
| US20180282324A1 (en) | Crystalline forms of a pyrrolopyridine compound | |
| RU2021110821A (ru) | Применение ингибитора катепсина s против образования противолекарственных антител |